Common Cold T-Cells Can Fight Covid: ICL Study

The video discusses the role of T cells, induced by previous common cold infections, in providing natural immunity against COVID-19. It highlights that some people exposed to COVID-19 do not get infected due to these T cells. The discussion extends to the development of vaccines, emphasizing the potential for a universal vaccine that targets internal virus proteins, offering protection against all variants. The video also clarifies that common cold immunity does not guarantee protection against COVID-19 and stresses the importance of vaccination.

What is the primary reason some people exposed to COVID-19 do not get infected?

• They have memory T cells from previous common cold infections.

• They have a strong antibody response.

• They have been vaccinated multiple times.

• They have a natural resistance to all viruses.

How do T cells from common colds protect against COVID-19 variants?

• By recognizing the spike protein on the virus surface.

• By recognizing internal proteins that are conserved across variants.

• By producing antibodies that neutralize the virus.

• By mutating to adapt to new variants.

Which of the following is NOT a reason why T cells can protect against COVID-19 variants?

• They can cross-recognize different viruses.

• They are not affected by surface protein mutations.

• They recognize rapidly mutating spike proteins.

• They target conserved internal proteins.

What is a universal vaccine expected to achieve?

• Work only for people with existing T cell immunity.

• Offer protection against all current and future COVID-19 variants.

• Provide immunity against only the original COVID-19 strain.

• Eliminate the need for any other vaccines.

What is a key advantage of T cell immunity over antibody immunity?

• T cell immunity requires fewer booster shots.

• T cell immunity is more effective against bacteria.

• T cell immunity lasts longer than antibody immunity.

• T cell immunity is faster to develop.

Why might a universal vaccine take longer to get approval compared to initial COVID-19 vaccines?

• Due to the complexity of the vaccine technology.

• Because the emergency approval speed might be less.

• Because it targets a wider range of viruses.

• Due to increased safety concerns.

What is the role of mRNA in the development of a universal vaccine?

• To speed up the approval process.

• To include instructions for internal proteins.

• To replace existing vaccines.

• To create antibodies against the virus.